News

Deutsche Bank Keeps Their Buy Rating on Novartis AG (NOVN)
According to TipRanks, Papadakis is a 4-star analyst with an average return of 3.8% and a 52.68% success rate. Papadakis covers the Healthcare sector, focusing on stocks such as Novo Nordisk, Novartis ...
Berenberg Bank Maintains a Hold Rating on Novartis (NVS)
Novartis AG (NYSE:NVS) is one of the 11 Best Drug Stocks to Buy According to Hedge Funds. On June 12, Berenberg Bank analyst ...
Deutsche Bank Remains a Buy on Novartis (NVS) With a CHF115 PT
Novartis AG (NYSE:NVS) is one of the 10 Undervalued European Stocks to Invest in Now. Deutsche Bank analyst Emmanuel ...
Kirkland’s Regeneron-Novartis Roles Spark Removal Bid (Correct)
Regeneron Inc. seeks to disqualify Kirkland & Ellis from representing its opponent Novartis AG in a major antitrust and ...
UBS Reaffirms Their Hold Rating on Novartis AG (NOVN)
In a report released today, Matthew Weston from UBS maintained a Hold rating on Novartis AG (NOVN – Research Report), with a price target of CHF104.00. The company’s shares cl ...
Uveitis Treatment Market Size In The 7MM Was ~USD 1,468.66 Million In 2022 And Is Expected To Increase By 2034, Estimates Delveinsight
In the US, patients diagnosed with noninfectious uveitis (NIU) are higher in number than infectious uveitis (IU). In 2022, ...
Sarepta Therapeutics' Elevidys Liver Deaths Trigger Selloff, A Contrarian Opportunity
Sarepta's stock drops on ELEVIDYS safety concerns, yet potential remains for ambulatory patients. Click here to read an ...
Morningstar2d
Novartis AG Registered Shares
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...